Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Xtant Medical Holdings, Inc.Xtant Medical Reports 18% Revenue Growth to $35.4 Million in Q2 2025
Scienture Holdings, Inc.Scienture Holdings Reports No Revenue and Increased Losses in Latest Financial Filing
ATOSSA THERAPEUTICS, INC.Atossa Therapeutics Reports $15.1 Million Net Loss and Increased R&D Expenses for First Half of 2025
Ondas Inc.Ondas Holdings Reports 554% Revenue Growth to $6.27 Million in Latest Quarter
HYDROFARM HOLDINGS GROUP, INC.Hydrofarm Reports 28.4% Decline in Q2 2025 Net Sales, Initiates Restructuring Plan
Empery Digital, Inc.Empery Digital Reports $3.9 Million Net Loss and Revenue Decline for Q2 2025
Hour Loop, IncHour Loop, Inc. Reports Q2 2025 Financial Results with Revenue Decline and Increased Net Income
Bitcoin Depot Inc.Bitcoin Depot Reports 5.5% Revenue Growth to $172.1 Million in Q2 2025
Aprea Therapeutics, Inc.Aprea Therapeutics Reports $3.2 Million Net Loss in Q2 2025, Seeks Additional Funding
Coya Therapeutics, Inc.Coya Therapeutics Reports 95% Decline in Collaboration Revenue and Increased Net Loss for Q2 2025
QNB CORPQNB Corp. Reports Significant Financial Growth in Second Quarter of 2025
Monopar TherapeuticsMonopar Therapeutics Reports $2.5 Million Net Loss in Q2 2025, Increases R&D and G&A Expenses
Orchestra BioMed Holdings, Inc.Orchestra BioMed Reports 7% Revenue Growth in Q2 2025 Amid Increased Losses
SMITHFIELD FOODS INCSmithfield Foods Reports 11% Sales Increase in Q2 2025, Net Income Declines
Mereo BioPharma Group plcMereo BioPharma Reports $500,000 Revenue in Q2 2025, Net Loss Increases to $14.6 Million
TechTarget, Inc.TechTarget Reports 90% Revenue Growth but $398.7 Million Net Loss in Latest Quarter
TScan Therapeutics, Inc.TScan Therapeutics Reports Revenue Growth but Increased Net Loss in Q2 2025
Sable Offshore Corp.Sable Offshore Reports $128.1 Million Net Loss, Sees 22.6% Improvement in Latest Quarter
Grace Therapeutics, Inc.Grace Therapeutics Reports $3.36 Million Net Loss and Focuses on GTx-104 Development
Climb Bio, Inc.Climb Bio Reports $8.7 Million Net Loss, Advances Clinical Trials for Budoprutug
Passage BIO, Inc.Passage Bio Reports Improved Financial Results with Reduced Losses in Q2 2025
Centessa Pharmaceuticals plcCentessa Pharmaceuticals Reports Q2 2025 Financial Results with Increased Net Loss
Korro Bio, Inc.Korro Bio Reports $1.5 Million Collaboration Revenue and Increased Operating Losses in Q2 2025
Adverum Biotechnologies, Inc.Adverum Biotechnologies Reports $49.2 Million Net Loss and Financial Challenges in Latest Filing
Optex Systems Holdings IncOptex Systems Reports 22.6% Revenue Growth to $11.1 Million in Latest Quarter